About: CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. The company also develops Auxora for the treatment of ulcerative colitis, traumatic brain injury, and allergic asthma; and oral CRAC channel inhibitors for use in chronic inflammatory and immunologic disease. The company is based in La Jolla, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.10 (-8.71%)
CALC NASDAQ CalciMedica, Inc. Common Stock
CalciMedica, Inc. Common Stock share price
CALC price activity
Last Price
$1.100
Change (24hr)
-0.11 USD (-8.71%)
Volume
74.94K
Volume (4w avg)
-
Open
$1.23
Day Range
$1.10 - $1.23
Previous Close
$1.21
Last Trade
13 Oct, 5:30 pm GMT+0
Delayed
13 Oct, 5:30 pm GMT+0
CALC price performance
Delayed
13 Oct, 5:30 pm GMT+0
CALC Market Signals